<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03698799</url>
  </required_header>
  <id_info>
    <org_study_id>077/2561(EC4)</org_study_id>
    <nct_id>NCT03698799</nct_id>
  </id_info>
  <brief_title>Adherence to LPV in SICU and Associated Clinical Outcomes</brief_title>
  <official_title>Adherence Rate to Lung Protective Mechanical Ventilation in Patients Admitted to Surgical Intensive Care Units and Associated Clinical Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lung Protective Ventilation strategy (LPV) with low tidal volume and adequate positive
      end-expiratory pressure is recommended for not only patients with acute respiratory distress
      syndrome (ARDS) but also those without ARDS too. From previous studies, adherence to LPV
      strategy reported is only 40% and data is limited in surgical patients. The investigators aim
      to describe ventilation management and find out the adherence rate to LPV strategy applied to
      surgical patients admitted to the surgical intensive care unit (SICU) and their associated
      outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mechanical ventilation (MV) is one of the one organ support most frequently applied to
      patients admitted to intensive care units (ICUs). Despite considering as a life-saving
      intervention, MV may have detrimental effects, namely ventilator-induced lung injury (VILI).
      A mechanical breath with positive airway pressure may overstretch alveoli, especially in the
      non-dependent part of the lungs, and subsequently result in barotrauma and volutrauma. While
      cyclic opening and closing of alveoli during mechanical breath due to alveolar collapse at
      the end of expiration can cause atelec-trauma or cyclic atelectasis. All of these can lead to
      the activation of respiratory and systemic inflammatory response, so-called bio-trauma. To
      minimize the effects of MV on VILI, the lung protective mechanical ventilation (LPV) strategy
      have been proposed and now generally accepted as a standard practice in mechanically
      ventilated patients. The LPV strategy basically consists of ventilation with the low tidal
      volume of 6-8 mL/kg of predicted body weight (PBW) with limited plateau pressure of less than
      30 cm H2O plus applying sufficient amount of positive end-expiratory pressure (PEEP) to
      prevent atelectasis. The LPV strategy has been clearly demonstrated benefits in not only
      patients with acute respiratory distress syndrome (ARDS) but also those with normal lungs
      including lessened respiratory and systemic inflammatory response and injured lungs,
      decreased duration of MV and length of stay (LOS), improved organ failure, and decreased
      pulmonary and other complications as well as mortality. Nevertheless, the adherence rate to
      the LPV strategy reported in the literatures is only approximately 40% in mechanically
      ventilated patients. For surgical patients, approximately 65% of those admitted to ICU
      require MV support either following operation or during their stay in ICU. To date, there is
      limited data regarding MV management in surgical patients who required MV support
      perioperatively. In addition, the difference in perioperative MV practices and their
      associated clinical outcomes has been not well determined in this setting. The aim of this
      study is to explore the current practice of MV according to the LPV strategy applied to
      surgical patients admitted to surgical ICU (SICU) and their associated clinical outcome. The
      primary outcome of this study is to determine the adherence rate to the LPV strategy at the
      initiation of MV support in mechanically ventilated patients in SICU. The LPV strategy in
      this study is defined as ventilation with the tidal volume of &lt;8 mL/kg of PBW plus applying
      PEEP of at least 5 cm of water. The secondary outcomes are factors associated with the
      adherence to the LPV strategy, incidences of pulmonary and other complications, LOS in SICU
      and in hospital, SICU and hospital discharge status, and status at 28 and 90 days following
      the initiation of MV support. Patients are divided into two groups, LPV and Non-LPV,
      according to their MV setting and clinical outcomes are statistically compared between
      groups.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 9, 2018</start_date>
  <completion_date type="Actual">March 20, 2020</completion_date>
  <primary_completion_date type="Actual">June 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence rate to LPV strategy at the initiation of MV support</measure>
    <time_frame>During the first 24 hours following the initiation of MV support</time_frame>
    <description>The LPV strategy is defined as ventilation with tidal volume of &lt;8 mL/kg of PBW plus applying PEEP of at least 5 cm H2O.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidences of pulmonary and other complications</measure>
    <time_frame>During the first 7 consecutive days following the initiation of MV support</time_frame>
    <description>Pulmonary complications include pneumonia, ARDS, atelectasis, restoration of MV support after liberation from MV, pleural effusion, cardiogenic pulmonary edema, pneumothorax and new pulmonary infiltration. Other complications include stroke, myocardial ischemia/infarction, arrhythmias, acute kidney injury, sepsis, new infection other than pneumonia, and re-admission to the SICU.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in SICU and in hospital</measure>
    <time_frame>Up to 90 days following the initiation of MV support</time_frame>
    <description>Total days of stay in SICU and in hospital following the initiation of MV support.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SICU and hospital discharge status, and status at 28 and 90 days</measure>
    <time_frame>Up to 90 days following the initiation of MV support</time_frame>
    <description>Status whether alive or decease</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">306</enrollment>
  <condition>Adult</condition>
  <condition>Guideline Adherence</condition>
  <condition>Humans</condition>
  <condition>Intensive Care Units</condition>
  <condition>Perioperative/Postoperative Complications</condition>
  <condition>Respiration, Artificial</condition>
  <condition>Tidal Volume</condition>
  <arm_group>
    <arm_group_label>LPV</arm_group_label>
    <description>Patients receive LPV strategy at the initiation of MV support. The LPV strategy is defined as ventilation with tidal volume of &lt;8 mL/kg of PBW plus applying PEEP of at least 5 cm H2O.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-LPV</arm_group_label>
    <description>Patients do not receive LPV strategy at the initiation of MV support.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All patients whose age of 18 years old or more admitted to two participating SICU and
        requiring MV support, either at SICU admission or during stay in SICU, via either
        endotracheal or tracheostomy tube with the anticipated duration of 12 hours or more without
        exclusion criteria are included.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients whose age of 18 years old or more

          -  Patients admitted to two participating SICU

          -  Patients requiring MV support with the anticipated duration of 12 hours or more

        Exclusion Criteria:

          -  Patients not requiring MV support during SICU stay

          -  Patients requiring MV support for less than 12 hours in SICU

          -  Patients requiring MV support for more than 24 hours prior to SICU admission

          -  Patients included in this study once and re-admitted to the SICU

          -  Patients requiring non-invasive MV support

          -  Moribund or terminal cases

          -  Patients who refuse to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Annop Piriyapatsom, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Siriraj Hospital</name>
      <address>
        <city>Bangkoknoi</city>
        <state>Bangkok</state>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <reference>
    <citation>Sutherasan Y, Vargas M, Pelosi P. Protective mechanical ventilation in the non-injured lung: review and meta-analysis. Crit Care. 2014 Mar 18;18(2):211. doi: 10.1186/cc13778. Review.</citation>
    <PMID>24762100</PMID>
  </reference>
  <reference>
    <citation>Biehl M, Kashiouris MG, Gajic O. Ventilator-induced lung injury: minimizing its impact in patients with or at risk for ARDS. Respir Care. 2013 Jun;58(6):927-37. doi: 10.4187/respcare.02347. Review.</citation>
    <PMID>23709192</PMID>
  </reference>
  <reference>
    <citation>Terragni P, Ranieri VM, Brazzi L. Novel approaches to minimize ventilator-induced lung injury. Curr Opin Crit Care. 2015 Feb;21(1):20-5. doi: 10.1097/MCC.0000000000000172. Review.</citation>
    <PMID>25546532</PMID>
  </reference>
  <reference>
    <citation>Petrucci N, De Feo C. Lung protective ventilation strategy for the acute respiratory distress syndrome. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD003844. doi: 10.1002/14651858.CD003844.pub4. Review.</citation>
    <PMID>23450544</PMID>
  </reference>
  <reference>
    <citation>Wang C, Wang X, Chi C, Guo L, Guo L, Zhao N, Wang W, Pi X, Sun B, Lian A, Shi J, Li E. Lung ventilation strategies for acute respiratory distress syndrome: a systematic review and network meta-analysis. Sci Rep. 2016 Mar 9;6:22855. doi: 10.1038/srep22855. Review.</citation>
    <PMID>26955891</PMID>
  </reference>
  <reference>
    <citation>Serpa Neto A, Cardoso SO, Manetta JA, Pereira VG, Esp√≥sito DC, Pasqualucci Mde O, Damasceno MC, Schultz MJ. Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis. JAMA. 2012 Oct 24;308(16):1651-9. doi: 10.1001/jama.2012.13730.</citation>
    <PMID>23093163</PMID>
  </reference>
  <reference>
    <citation>Neto AS, Simonis FD, Barbas CS, Biehl M, Determann RM, Elmer J, Friedman G, Gajic O, Goldstein JN, Linko R, Pinheiro de Oliveira R, Sundar S, Talmor D, Wolthuis EK, Gama de Abreu M, Pelosi P, Schultz MJ; PROtective Ventilation Network Investigators. Lung-Protective Ventilation With Low Tidal Volumes and the Occurrence of Pulmonary Complications in Patients Without Acute Respiratory Distress Syndrome: A Systematic Review and Individual Patient Data Analysis. Crit Care Med. 2015 Oct;43(10):2155-63. doi: 10.1097/CCM.0000000000001189. Review.</citation>
    <PMID>26181219</PMID>
  </reference>
  <results_reference>
    <citation>Santamaria JD, Tobin AE, Reid DA. Do we practise low tidal-volume ventilation in the intensive care unit? a 14-year audit. Crit Care Resusc. 2015 Jun;17(2):108-12.</citation>
    <PMID>26017128</PMID>
  </results_reference>
  <results_reference>
    <citation>Kalhan R, Mikkelsen M, Dedhiya P, Christie J, Gaughan C, Lanken PN, Finkel B, Gallop R, Fuchs BD. Underuse of lung protective ventilation: analysis of potential factors to explain physician behavior. Crit Care Med. 2006 Feb;34(2):300-6.</citation>
    <PMID>16424706</PMID>
  </results_reference>
  <results_reference>
    <citation>Umoh NJ, Fan E, Mendez-Tellez PA, Sevransky JE, Dennison CR, Shanholtz C, Pronovost PJ, Needham DM. Patient and intensive care unit organizational factors associated with low tidal volume ventilation in acute lung injury. Crit Care Med. 2008 May;36(5):1463-8. doi: 10.1097/CCM.0b013e31816fc3d0.</citation>
    <PMID>18434907</PMID>
  </results_reference>
  <results_reference>
    <citation>Chen YF, Lim CK, Ruan SY, Jerng JS, Lin JW, Kuo PH, Wu HD, Yu CJ. Factors associated with adherence to low-tidal volume strategy for acute lung injury and acute respiratory distress syndrome and their impacts on outcomes: an observational study and propensity analysis. Minerva Anestesiol. 2014 Nov;80(11):1158-68. Epub 2014 Feb 25.</citation>
    <PMID>24569355</PMID>
  </results_reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>September 27, 2018</study_first_submitted>
  <study_first_submitted_qc>October 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2018</study_first_posted>
  <last_update_submitted>June 3, 2020</last_update_submitted>
  <last_update_submitted_qc>June 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Annop Piriyapatsom, MD</investigator_full_name>
    <investigator_title>Lecturer, Department of Anesthesiology, Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Adherence</keyword>
  <keyword>Intensive Care Unit</keyword>
  <keyword>Lung Protective Strategy</keyword>
  <keyword>Mechanical Ventilation</keyword>
  <keyword>Perioperative Critical Care</keyword>
  <keyword>Surgical</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 10, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/99/NCT03698799/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

